ATE392202T1 - Spritzgiessbare feste verabreichungsysteme - Google Patents

Spritzgiessbare feste verabreichungsysteme

Info

Publication number
ATE392202T1
ATE392202T1 AT99933818T AT99933818T ATE392202T1 AT E392202 T1 ATE392202 T1 AT E392202T1 AT 99933818 T AT99933818 T AT 99933818T AT 99933818 T AT99933818 T AT 99933818T AT E392202 T1 ATE392202 T1 AT E392202T1
Authority
AT
Austria
Prior art keywords
delivery systems
injection moldable
moldable solid
solid delivery
implant composition
Prior art date
Application number
AT99933818T
Other languages
English (en)
Inventor
Richard Dunn
Bhagya Chandrashekar
Kathleen Mcenery
Original Assignee
Qlt Usa Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Qlt Usa Inc filed Critical Qlt Usa Inc
Application granted granted Critical
Publication of ATE392202T1 publication Critical patent/ATE392202T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Dermatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
AT99933818T 1998-07-28 1999-07-08 Spritzgiessbare feste verabreichungsysteme ATE392202T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/123,723 US6261583B1 (en) 1998-07-28 1998-07-28 Moldable solid delivery system

Publications (1)

Publication Number Publication Date
ATE392202T1 true ATE392202T1 (de) 2008-05-15

Family

ID=22410471

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99933818T ATE392202T1 (de) 1998-07-28 1999-07-08 Spritzgiessbare feste verabreichungsysteme

Country Status (8)

Country Link
US (1) US6261583B1 (de)
EP (1) EP1100460B1 (de)
JP (1) JP2002537221A (de)
AT (1) ATE392202T1 (de)
AU (1) AU4979499A (de)
CA (1) CA2338605C (de)
DE (1) DE69938552D1 (de)
WO (1) WO2000006117A1 (de)

Families Citing this family (59)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7888466B2 (en) 1996-01-11 2011-02-15 Human Genome Sciences, Inc. Human G-protein chemokine receptor HSATU68
AUPO907697A0 (en) 1997-09-09 1997-10-02 Day, Robert Edward Chemical supplementation of bone
AU2001288829A1 (en) * 2000-09-06 2002-03-22 Ap Pharma, Inc. Degradable polyacetal polymers
US6786930B2 (en) 2000-12-04 2004-09-07 Spineco, Inc. Molded surgical implant and method
US6590059B2 (en) * 2001-05-11 2003-07-08 Ap Pharma, Inc. Bioerodible polyorthoesters from dioxolane-based diketene acetals
US20030152630A1 (en) * 2001-05-11 2003-08-14 Ng Steven Y. PEG-POE, PEG-POE-PEG, and POE-PEG-POE block copolymers
US7750063B2 (en) 2001-10-24 2010-07-06 Pentron Clinical Technologies, Llc Dental filling material
US7303817B2 (en) 2001-10-24 2007-12-04 Weitao Jia Dental filling material
US7211136B2 (en) 2001-10-24 2007-05-01 Pentron Clinical Technologies, Llc Dental filling material
US7204874B2 (en) 2001-10-24 2007-04-17 Pentron Clinical Technologies, Llc Root canal filling material
US7204875B2 (en) 2001-10-24 2007-04-17 Pentron Clinical Technologies, Llc Dental filling material
US6524606B1 (en) * 2001-11-16 2003-02-25 Ap Pharma, Inc. Bioerodible polyorthoesters containing amine groups
US6926903B2 (en) * 2001-12-04 2005-08-09 Inion Ltd. Resorbable polymer composition, implant and method of making implant
EP1344538A1 (de) * 2002-03-14 2003-09-17 Degradable Solutions AG Poröses und bioabbaubares Implantatmaterial und Verfahren zu seiner Herstellung
US7432245B2 (en) * 2002-06-07 2008-10-07 Abbott Laboratories Inc. Pharmaceutical formulation comprising a peptide angiogenesis inhibitor
US20040001889A1 (en) 2002-06-25 2004-01-01 Guohua Chen Short duration depot formulations
KR101476067B1 (ko) 2002-09-06 2014-12-23 인설트 테라페틱스, 인코퍼레이티드 공유결합된 치료제 전달을 위한 사이클로덱스트린-기초 중합체
RU2005114007A (ru) 2002-10-09 2005-10-10 Инсерт Терапьютикс, Инк. (Us) Материалы на основе циклодекстринов, их композиции и применение
HUP0203719A2 (en) * 2002-10-31 2007-09-28 Stepan Dr Gudak Polyuretan composition for fillin blood vessels and method of aplication of it
US20040156894A1 (en) * 2003-02-07 2004-08-12 Grother Leon Paul Use of edible acids in fast-dispersing pharmaceutical solid dosage forms
WO2004081196A2 (en) * 2003-03-11 2004-09-23 Qlt Usa Inc. Formulations for cell- schedule dependent anticancer agents
AU2003233838A1 (en) * 2003-06-04 2005-01-04 Inion Ltd Biodegradable implant and method for manufacturing one
US20070224278A1 (en) * 2003-11-12 2007-09-27 Lyons Robert T Low immunogenicity corticosteroid compositions
US20050101582A1 (en) * 2003-11-12 2005-05-12 Allergan, Inc. Compositions and methods for treating a posterior segment of an eye
US20060141049A1 (en) * 2003-11-12 2006-06-29 Allergan, Inc. Triamcinolone compositions for intravitreal administration to treat ocular conditions
CA2553381C (en) 2004-01-20 2011-03-22 Allergan, Inc. Compositions for localized therapy of the eye, comprising preferably triamcinolone acetonide and hyaluronic acid
US20050180951A1 (en) * 2004-02-12 2005-08-18 Tsuneya Ohno Combined immunotherapy of fusion cells and interleukin-12 for treatment of cancer
US8119154B2 (en) 2004-04-30 2012-02-21 Allergan, Inc. Sustained release intraocular implants and related methods
US8147865B2 (en) 2004-04-30 2012-04-03 Allergan, Inc. Steroid-containing sustained release intraocular implants and related methods
US8163030B2 (en) * 2004-05-06 2012-04-24 Degradable Solutions Ag Biocompatible bone implant compositions and methods for repairing a bone defect
BRPI0513243B8 (pt) 2004-07-12 2021-05-25 Allergan Inc composições oftálmicas e respectivos usos
EP1804751A2 (de) * 2004-10-04 2007-07-11 QLT USA, Inc. Okulare abgabe von polymer-abgabeformulierungen
US8313763B2 (en) 2004-10-04 2012-11-20 Tolmar Therapeutics, Inc. Sustained delivery formulations of rapamycin compounds
US20060253068A1 (en) * 2005-04-20 2006-11-09 Van Bilsen Paul Use of biocompatible in-situ matrices for delivery of therapeutic cells to the heart
US8852638B2 (en) 2005-09-30 2014-10-07 Durect Corporation Sustained release small molecule drug formulation
NZ597082A (en) 2005-10-13 2013-11-29 Human Genome Sciences Inc Methods and Compositions for Use in Treatment of Patients with Autoantibody Positive Diseases
MX2008009125A (es) 2006-01-18 2008-10-23 Qps Llc Composiciones farmaceuticas con estabilidad mejorada.
MX2009000434A (es) 2006-07-11 2009-01-29 Qps Llc Composiciones farmaceuticas para la distribucion de liberacion sostenida de peptidos.
US8076448B2 (en) 2006-10-11 2011-12-13 Tolmar Therapeutics, Inc. Preparation of biodegradable polyesters with low-burst properties by supercritical fluid extraction
US20080176958A1 (en) 2007-01-24 2008-07-24 Insert Therapeutics, Inc. Cyclodextrin-based polymers for therapeutics delivery
WO2008097525A2 (en) 2007-02-05 2008-08-14 Potentia Pharmaceuticals, Inc. Local complement inhibition for treatment of complement-mediated disorders
US9187593B2 (en) 2007-02-15 2015-11-17 Tolmar Therapeutics, Inc. Low burst polymers and methods to produce polymer
JP2010531807A (ja) 2007-05-25 2010-09-30 トルマー セラピューティクス， インコーポレイテッド リスペリドン化合物の徐放送達製剤
US20090181068A1 (en) * 2008-01-14 2009-07-16 Dunn Richard L Low Viscosity Liquid Polymeric Delivery System
AU2009255675B2 (en) * 2008-06-03 2014-10-09 Tolmar Therapeutics, Inc. Controlled release copolymer formulation with improved release kinetics
US9486531B2 (en) * 2008-06-03 2016-11-08 Indivior Uk Limited Dehydrated hydrogel inclusion complex of a bioactive agent with flowable drug delivery system
WO2010093993A2 (en) 2009-02-12 2010-08-19 Human Genome Sciences, Inc. Use of b lymphocyte stimulator protein antagonists to promote transplantation tolerance
GB2513060B (en) 2010-06-08 2015-01-07 Rb Pharmaceuticals Ltd Microparticle buprenorphine suspension
US9272044B2 (en) 2010-06-08 2016-03-01 Indivior Uk Limited Injectable flowable composition buprenorphine
EA027046B1 (ru) 2010-12-29 2017-06-30 Мединселл Биоразлагаемая композиция для доставки лекарственных средств, способ ее получения и ее применение
US20140094432A1 (en) 2012-10-02 2014-04-03 Cerulean Pharma Inc. Methods and systems for polymer precipitation and generation of particles
GB201404139D0 (en) 2014-03-10 2014-04-23 Rb Pharmaceuticals Ltd Sustained release buprenorphine solution formulations
US20160106804A1 (en) 2014-10-15 2016-04-21 Yuhua Li Pharmaceutical composition with improved stability
AU2015341490C1 (en) 2014-11-07 2021-03-11 Indivior Uk Limited Buprenorphine dosing regimens
AU2016355236C1 (en) 2015-11-16 2022-09-22 Medincell A method for morselizing and/or targeting pharmaceutically active principles to synovial tissue
US10646484B2 (en) 2017-06-16 2020-05-12 Indivior Uk Limited Methods to treat opioid use disorder
MX2020006188A (es) 2017-12-18 2020-09-17 Foresee Pharmaceuticals Co Ltd Composiciones farmaceuticas que tienen una duracion de liberacion seleccionada.
EP4090353A4 (de) 2020-01-13 2023-08-09 Durect Corporation Arzneimittelabgabesysteme mit verzögerter freisetzung mit reduzierten verunreinigungen und verwandte verfahren
JP2024503402A (ja) 2021-01-12 2024-01-25 デュレクト コーポレーション 徐放性薬物送達システム及び関連の方法

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3463158A (en) 1963-10-31 1969-08-26 American Cyanamid Co Polyglycolic acid prosthetic devices
US3919773A (en) 1973-12-20 1975-11-18 Sybron Corp Direct moldable implant material
IL59063A (en) 1979-01-11 1983-12-30 Key Pharma Polymeric diffusion matrix for release of pharmaceutical dosage
US5366734A (en) 1981-02-16 1994-11-22 Zeneca Limited Continuous release pharmaceutical compositions
US4774091A (en) 1983-10-14 1988-09-27 Sumitomo Pharmaceuticals Company, Ltd. Long-term sustained-release preparation
US4722948A (en) 1984-03-16 1988-02-02 Dynatech Corporation Bone replacement and repair putty material from unsaturated polyester resin and vinyl pyrrolidone
US4595713A (en) 1985-01-22 1986-06-17 Hexcel Corporation Medical putty for tissue augmentation
US4650665A (en) 1985-02-08 1987-03-17 Ethicon, Inc. Controlled release of pharmacologically active agents from an absorbable biologically compatible putty-like composition
US4568536A (en) 1985-02-08 1986-02-04 Ethicon, Inc. Controlled release of pharmacologically active agents from an absorbable biologically compatible putty-like composition
US4702917A (en) * 1985-11-18 1987-10-27 Research Triangle Institute Porous bioabsorbable polyesters
CA1260488A (en) 1986-07-07 1989-09-26 Alexander M. Henderson Absorbable bone wax formulation
GB8626623D0 (en) 1986-11-07 1986-12-10 Shirley Inst Vascular prosthesis
US4800219A (en) 1986-12-22 1989-01-24 E. I. Du Pont De Nemours And Company Polylactide compositions
DE3734223A1 (de) 1987-10-09 1989-04-20 Boehringer Ingelheim Kg Implantierbares, biologisch abbaubares wirkstofffreigabesystem
US5149052A (en) 1987-11-16 1992-09-22 Kingston Technologies, Inc. Precision molding of polymers
US4938763B1 (en) 1988-10-03 1995-07-04 Atrix Lab Inc Biodegradable in-situ forming implants and method of producing the same
US5487897A (en) 1989-07-24 1996-01-30 Atrix Laboratories, Inc. Biodegradable implant precursor
US5324519A (en) * 1989-07-24 1994-06-28 Atrix Laboratories, Inc. Biodegradable polymer composition
US5077049A (en) 1989-07-24 1991-12-31 Vipont Pharmaceutical, Inc. Biodegradable system for regenerating the periodontium
TW247878B (de) 1991-07-02 1995-05-21 Takeda Pharm Industry Co Ltd
AU2605592A (en) * 1991-10-15 1993-04-22 Atrix Laboratories, Inc. Polymeric compositions useful as controlled release implants
US5681873A (en) 1993-10-14 1997-10-28 Atrix Laboratories, Inc. Biodegradable polymeric composition
DK0754032T3 (da) 1994-04-08 2002-04-02 Atrix Lab Inc Flydende frigivelsessammensætninger

Also Published As

Publication number Publication date
CA2338605A1 (en) 2000-02-10
CA2338605C (en) 2009-02-24
EP1100460A1 (de) 2001-05-23
JP2002537221A (ja) 2002-11-05
US6261583B1 (en) 2001-07-17
WO2000006117A1 (en) 2000-02-10
DE69938552D1 (de) 2008-05-29
EP1100460B1 (de) 2008-04-16
AU4979499A (en) 2000-02-21

Similar Documents

Publication Publication Date Title
ATE392202T1 (de) Spritzgiessbare feste verabreichungsysteme
DE69823055D1 (de) Abgabe von polyethylene glycol-molekül- konjugaten aus abbaubarem hydrogel
ATE289214T1 (de) Dünner polymerfilm als medikamentenreservoir
CA2416383A1 (en) Solution-, dispersion- or emulsion-producing film dermatics
DE69429434D1 (de) Implantierbare vorrichtung zur arzneiabgabe
DE60316579D1 (de) System zur abgabe von wirkstoffen mit einem hydrophoben cellulose-derivat
AU1728901A (en) Electropolymerizable monomers and polymeric coatings on implantable devices
ATE467430T1 (de) Endovaskuläres implantat mit einer zumindest abschnittsweisen aktiven beschichtung aus ratjadon und/oder einem ratjadon-derivat
BR0012588A (pt) Copolìmero em bloco, composição para suprimento de agente bioativo, e, formulação de medicamento para implantação subcutânea ou injeção intravenosa
TW200514581A (en) In-situ gelling drug delivery system
ES2163008T3 (es) Procedimiento para la obtencion de preparados de principios activos en forma de una disolucion solida de principio activo en una matriz polimera, asi como preparados de principios activos obtenidos con este procedimiento.
ATE317690T1 (de) Flüssige zusammensetzungen zur arzneistoffabgabe
ATE334633T1 (de) Zahnprothese mit wirkstoffabgabevorrichtung
NO995313L (no) Mikroartikler nyttige som ultrasoniske kontrastmidler og til levering av legemidler i blodbanen
GR3030732T3 (en) Pharmaceutical compositions including a drug, a cross-linked polymeric substance, an oil, and a surface active agent.
DE69821510D1 (de) Mit apatit beschichtete feste zusammensetzung
NZ502376A (en) Antifouling polymers comprising a polymer selected form EVA copolymer, HDPE, sodium ionomer and ethylene acrylic acid polmer, and a isothiazolone or furanone antifouling agent
FI970934A0 (fi) Implantoitava valukappale vaikuttavien aineiden annostelemiseksi kasveihin
ATE224208T1 (de) Wasserlöslicher film
PE20030402A1 (es) Productos para la axila con componentes de bloqueo de agua
WO1998030245A3 (de) Injizierbares implantat
ATE205709T1 (de) Polymere ionene als anthelminthika in tieren
ATE201559T1 (de) Pflanzenbehandlungsmittel
ES2178631T3 (es) Composicion a base de un oligomero y un polimero, inyectable y biodegradable.
ATE293958T1 (de) Mikropartikel zur gesteuerten wirkstoffabgabe biologisch aktiver moleküle

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties